Cell Therapy Bioprocessing Market Overview
The cell therapy bioprocessing market is one of the fastest growing sectors in the broader biopharmaceutical industry. Cell therapy is the application of living cells to treat medical conditions, and the bioprocessing aspect relates to the manufacture and production of these cell-based therapies.
The cell therapy bioprocessing is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.5% from 2021-2028.
Market Segmentation
By Product Type
- Technology
- Cell Type
By Indication
- Cardiovascular Disease
- Oncology
- Wound Healing
- Orthopedic
By End User
- Hospitals and Clinics
- Diagnostic Centers
- Regenerative Medicine Centers
- Academic and Research Institute
The cell therapy bioprocessing market is expected to continue its high growth in the coming years on account of high demand for customized and targeted treatments, the establishment of advanced technologies in bioprocessing, and the regulatory backing for the industrialization of treatments based on cell therapy.
